Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000523216 | SCV000616952 | uncertain significance | not provided | 2022-09-02 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Labcorp Genetics |
RCV000706517 | SCV000835572 | likely benign | Long QT syndrome | 2024-12-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002350146 | SCV002646936 | likely benign | Cardiovascular phenotype | 2023-09-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004767320 | SCV005381732 | uncertain significance | not specified | 2024-08-27 | criteria provided, single submitter | clinical testing |